| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K51831558 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | AICAR | GDSC1000 | pan-cancer | AAC | 0.0067 | 0.8 |
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | -0.0078 | 0.8 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | 0.0066 | 0.8 |
| mRNA | brivanib | CTRPv2 | pan-cancer | AAC | -0.0078 | 0.8 |
| mRNA | navitoclax:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0074 | 0.8 |
| mRNA | AZD-2281 | CTRPv2 | pan-cancer | AAC | 0.0076 | 0.8 |
| mRNA | Elesclomol | GDSC1000 | pan-cancer | AAC | -0.007 | 0.8 |
| mRNA | Camptothecin | GDSC1000 | pan-cancer | AAC | 0.0069 | 0.8 |
| mRNA | necrostatin-1 | CTRPv2 | pan-cancer | AAC | 0.008 | 0.8 |